FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/20/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients
(NASDAQ: FOCL) Delayed: 4.15 -0.13 (3.04%)
Previous Close $4.28    52 Week High $ 
Open $4.29    52 Week Low $ 
Day High $4.29    P/E N/A 
Day Low $4.05    EPS $ 
Volume 104,833